High levels of ROS can induce cellular damage and promote many inflammatory states including cancer (Perwez Hussain and Harris, 2007; Reuter et al., 2010; Burton and Jauniaux, 2011) by recruiting inflammatory markers such as cytokines and chemokines and stimulating NF-κB signaling (Reuter et al., 2010). Here, NFKB1 is linked to cancer.